Elliott demands €74.4 per share to support Stada takeover
Hedge fund Elliott Management has announced it will not support Bain and Cinven's domination agreement for the takeover of German pharmaceutical company Stada at a price of less than €74.4 per share.
Elliott held a stake of 11.43% in the company as of 28 August, according to publicly available information.
Bain and Cinven announced on 25 August that they had entered into domination and profit and loss pooling negotiations with Stada through their bidding company Nidda Healthcare. The GPs offered €66.25 per share as part of their offer.
Under German takeover law, the bidder must acquire 95% of outstanding shares in most cases before it can exercise a squeeze-out option for the compulsory purchase of the remaining shares.
Elliott states that its principal objective is to generate a return that is as high as is consistent with a goal of minimising losses during adverse financial market periods.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









